Dr Eric O. Aboagye, PhD FMedSci

  • Professor of Cancer Pharmacology and Molecular Imaging, Imperial College London.
  • Fellow, United Kingdom Academy of Medical Sciences
  • Director, Cancer Imaging Centre, Imperial College London.
  • Co-director, Imperial College London Experimental Cancer Medicine’s Centre
  • Theme lead, NIHR Imperial Biomedical Research Centre Imaging Theme

Dr Eric Aboagye holds the position of Professor of Cancer Pharmacology and Molecular Imaging at Imperial College London, where he is Director of the Cancer Imaging Centre.

He obtained a Pharmacy degree from University of Science & Technology, Kumasi, Ghana, in 1989 and a Master’s degree in Pharmaceutical Analysis from Strathclyde University, Glasgow, UK, in 1991. In 1995 he completed his PhD in Cancer Pharmacology and Imaging from the Beatson Laboratories at the University of Glasgow. After post-doctoral training at the Johns Hopkins University in Baltimore, USA, he moved to Imperial College London as a senior research fellow in 1998 and was appointed Professor in 2006. He has remained at Imperial College since then.

Dr Aboagye’s primary research interest is in the field of molecular imaging: discovery, development and application of molecular imaging methods, particularly positron emission tomography and magnetic resonance imaging, to study tumour biology and novel therapies. Working at the interface of chemistry, mathematics, and biology, he has made fundamental discoveries in visualising complex cancer processes in living subjects, and translated these methods to provide advanced tools for detecting drug distribution and consequences of drug-target modulation in humans, as well as tools for early disease detection and objective response assessment. His research group is well known internationally for developing methodologies that permit visualisation and quantification of core tumour biologic phenotypes including cell proliferation, apoptosis, angiogenesis, hypoxia, and growth factor receptor signalling. More recently his team has also developed imaging tools to enable better characterisation of choline, glycogen and fatty acid metabolism. Mathematical modelling approaches for tracer kinetics and texture analysis have been developed and applied hand in hand with the chemical-biology approaches.

Dr Aboagye has received a number of awards including the British Association for Cancer Research Translational Research Award and the British Institute of Radiology Sir Mackenzie Davidson Medal. He was elected to fellowship of the United Kingdom Academy of Medical Sciences in 2010. He is author of over 200 publications and 12 patents on cancer drug development and imaging and has contributed to the early careers of excellent researchers including 20 PhD students who have graduated under his primary supervision and 35 post-doctoral fellows primarily mentored by him; several of these researchers have established their own research groups. Dr Aboagye has acted as an Advisor to international pharmaceutical & Imaging companies including GE Healthcare, LightPoint, GSK, Roche and Novartis Pharmaceuticals.

Please feel free to share this...